|
US4746653A
(en)
*
|
1986-02-28 |
1988-05-24 |
Ciba-Geigy Corporation |
Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals
|
|
GB9515975D0
(en)
*
|
1995-08-04 |
1995-10-04 |
Zeneca Ltd |
Chemical compounds
|
|
ES2210846T3
(es)
*
|
1997-11-20 |
2004-07-01 |
Cerus Corporation |
Nuevos psoralenos para inactivar agentes patogenos.
|
|
EP1368323B1
(en)
*
|
2001-02-14 |
2010-06-30 |
Warner-Lambert Company LLC |
Pyrimidine matrix metalloproteinase inhibitors
|
|
DOP2002000332A
(es)
*
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Inhibidores de piridina de metaloproteinasas de la matriz
|
|
DE10138578A1
(de)
*
|
2001-08-06 |
2003-02-27 |
Bayer Ag |
Heterocyclylarylsulfonamide
|
|
US6924276B2
(en)
*
|
2001-09-10 |
2005-08-02 |
Warner-Lambert Company |
Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
|
|
DE10160357A1
(de)
*
|
2001-12-08 |
2003-06-18 |
Aventis Pharma Gmbh |
Verwendung von Pyridin-2,4-dicarbonsäurediamiden und Pyrimidin-4,6-dicarbonsäurediamiden zur selektiven Inhibierung von Kollagenasen
|
|
US6933298B2
(en)
*
|
2001-12-08 |
2005-08-23 |
Aventis Pharma Deutschland Gmbh |
Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases
|
|
DE10251019A1
(de)
*
|
2002-11-02 |
2004-05-19 |
Aventis Pharma Deutschland Gmbh |
Neue Pyrimidin-4,6-dicarbonsäurediamide zur selektiven Inhibierung von Kollagenasen
|
|
US20050004111A1
(en)
*
|
2003-01-03 |
2005-01-06 |
Aventis Pharma Deutschland Gmbh |
Selective MMP-13 inhibitors
|
|
DE10300017A1
(de)
|
2003-01-03 |
2004-07-15 |
Aventis Pharma Deutschland Gmbh |
Selektive MMP 13 Inhibitoren
|
|
US20060173183A1
(en)
*
|
2004-12-31 |
2006-08-03 |
Alantos Pharmaceuticals, Inc., |
Multicyclic bis-amide MMP inhibitors
|
|
AU2006332694A1
(en)
*
|
2005-12-30 |
2007-07-12 |
Alantos Pharmaceuticals, Holding, Inc. |
Substituted bis-amide metalloprotease inhibitors
|
|
GB0614570D0
(en)
*
|
2006-07-21 |
2006-08-30 |
Glaxo Group Ltd |
Compounds
|
|
US20110269834A1
(en)
*
|
2008-08-21 |
2011-11-03 |
The Board Of Trustees Of The University Of Illinois |
Compounds and methods for treating respiratory diseases
|
|
FR2958849A1
(fr)
*
|
2010-04-14 |
2011-10-21 |
Boiron |
Medicament homeopathique a activite anti-cancereuse
|
|
WO2011129936A2
(en)
|
2010-04-16 |
2011-10-20 |
Kinex Pharmaceuticals, Llc |
Compositions and methods for the prevention and treatment of cancer
|
|
CN103249721B
(zh)
*
|
2010-10-18 |
2016-10-12 |
拉夸里亚创药株式会社 |
作为ttx-s阻滞剂的芳胺衍生物
|
|
TW201733984A
(zh)
*
|
2011-04-13 |
2017-10-01 |
雅酶股份有限公司 |
經取代之苯化合物
|
|
PE20150224A1
(es)
*
|
2012-05-11 |
2015-03-08 |
Abbvie Inc |
Inhibidores del nampt
|
|
US9505743B2
(en)
*
|
2012-10-15 |
2016-11-29 |
Aquilus Pharmaceuticals, Inc. |
Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases
|
|
EP3003275B1
(en)
*
|
2013-06-03 |
2020-11-18 |
Bar-Ilan University |
Liposomes for modulating wiskott-aldrich syndrome protein
|
|
EP3020710A4
(en)
*
|
2013-07-11 |
2016-12-14 |
Consejo Superior De Investig Científicas (Csic) |
OXAZOLIDINONE DERIVATIVES AS PPAR LIGANDS
|
|
CN104672241B
(zh)
*
|
2015-01-29 |
2018-04-24 |
王磊 |
吡咯并[2,3-d]嘧啶类化合物及其用途
|
|
US10112955B2
(en)
*
|
2015-10-29 |
2018-10-30 |
Effector Therapeutics, Inc. |
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
|
|
GB201610854D0
(en)
|
2016-06-21 |
2016-08-03 |
Entpr Therapeutics Ltd |
Compounds
|
|
GB201619694D0
(en)
|
2016-11-22 |
2017-01-04 |
Entpr Therapeutics Ltd |
Compounds
|
|
WO2018200833A1
(en)
*
|
2017-04-28 |
2018-11-01 |
Celgene International Ii Sarl |
Novel glp-1 receptor modulators
|
|
GB201717051D0
(en)
|
2017-10-17 |
2017-11-29 |
Enterprise Therapeutics Ltd |
Compounds
|
|
WO2019079609A1
(en)
*
|
2017-10-20 |
2019-04-25 |
The Regents Of The University Of California |
SEH / PDE4 DOUBLE INHIBITORS AVAILABLE ORAL
|
|
CN107954977A
(zh)
*
|
2017-12-15 |
2018-04-24 |
上海鼎雅药物化学科技有限公司 |
雷替曲塞中间体的合成方法
|
|
GB201801355D0
(en)
*
|
2018-01-26 |
2018-03-14 |
Enterprise Therapeutics Ltd |
Compounds
|
|
GB201808093D0
(en)
|
2018-05-18 |
2018-07-04 |
Enterprise Therapeutics Ltd |
Compounds
|
|
GB201908453D0
(en)
|
2019-06-12 |
2019-07-24 |
Enterprise Therapeutics Ltd |
Compounds for treating respiratory disease
|